Cheng, Bryan L.
Duminie, Sean P.
Mitei, Mercy
Pickhardt, Perry J.
Kanne, Jeffrey P.
Parker, Robert K.
Hartung, Michael P. https://orcid.org/0000-0002-0702-2080
Article History
Received: 9 January 2023
Revised: 18 February 2023
Accepted: 21 February 2023
First Online: 20 March 2023
Declarations
:
: Michael P Hartung analyzed and controlled the data, and is a consultant for Innovenn Inc. and Otsuka Pharmaceutical. This consulting work is not relevant to this manuscript. There are no relevant conflict of interests. The authors declare that they had full access to all of the data in this study and the authors take complete responsibility for the integrity of the data and the accuracy of the data analysis.